Milo Engoren1, Cynthia Arslanian-Engoren. 1. Department of Anesthesiology, St Vincent Mercy Medical Center, University of Toledo Health Sciences College, Toledo, Ohio 43608, USA. engoren@pol.net
Abstract
BACKGROUND: Erythrocyte blood transfusions are commonly used in intensive care units, yet little is known about their effects on long-term survival. OBJECTIVE: To determine the effect of erythrocyte blood transfusion in intensive care units on long-term survival. METHODS: Retrospective analysis of a prospectively collected database of 2213 patients admitted January 27, 2001, to April 30, 2002, to the cardiac, burn, neurological-neurosurgical, and combined medical-surgical intensive care units in a tertiary care, university-affiliated, urban medical center. Further analysis was done on a case-control subgroup (n=556) formed by matching scores on the Acute Physiology and Chronic Health Evaluation (APACHE) II and propensity scores. RESULTS: Although transfusion was univariably associated with increased risk of death at all 3 times (0-30, 31-180, and >180 days after admission to the unit), multivariable adjustment with Cox modeling showed that transfusion had no association with mortality for the first 2 intervals (0-30 and 31-180 days), but was associated with a 25% lower risk of death (hazard ratio, 0.75; 95% confidence interval, 0.57-0.99; P=.04) in patients who survived at least 180 days after admission to the unit. In the case-control patients, after correction for APACHE II risk of death and propensity to receive a transfusion, transfusion had no association with mortality for the first 2 intervals, but was associated with 29% lowered risk of death (hazard ratio, 0.71; 95% confidence interval, 0.50-0.99; P=.046). CONCLUSION: Blood transfusion was associated with a decreased risk of late (>180 days) death in intensive care patients.
BACKGROUND: Erythrocyte blood transfusions are commonly used in intensive care units, yet little is known about their effects on long-term survival. OBJECTIVE: To determine the effect of erythrocyte blood transfusion in intensive care units on long-term survival. METHODS: Retrospective analysis of a prospectively collected database of 2213 patients admitted January 27, 2001, to April 30, 2002, to the cardiac, burn, neurological-neurosurgical, and combined medical-surgical intensive care units in a tertiary care, university-affiliated, urban medical center. Further analysis was done on a case-control subgroup (n=556) formed by matching scores on the Acute Physiology and Chronic Health Evaluation (APACHE) II and propensity scores. RESULTS: Although transfusion was univariably associated with increased risk of death at all 3 times (0-30, 31-180, and >180 days after admission to the unit), multivariable adjustment with Cox modeling showed that transfusion had no association with mortality for the first 2 intervals (0-30 and 31-180 days), but was associated with a 25% lower risk of death (hazard ratio, 0.75; 95% confidence interval, 0.57-0.99; P=.04) in patients who survived at least 180 days after admission to the unit. In the case-control patients, after correction for APACHE II risk of death and propensity to receive a transfusion, transfusion had no association with mortality for the first 2 intervals, but was associated with 29% lowered risk of death (hazard ratio, 0.71; 95% confidence interval, 0.50-0.99; P=.046). CONCLUSION: Blood transfusion was associated with a decreased risk of late (>180 days) death in intensive care patients.
Authors: Henrik Bjursten; Alain Dardashti; Per Ederoth; Björn Brondén; Lars Algotsson Journal: Intensive Care Med Date: 2012-10-10 Impact factor: 17.440
Authors: Carlos E Arias-Morales; Nicoleta Stoicea; Alicia A Gonzalez-Zacarias; Diana Slawski; Sujatha P Bhandary; Theodosios Saranteas; Eva Kaminiotis; Thomas J Papadimos Journal: F1000Res Date: 2017-02-20
Authors: Kevin W McCool; Emmanuel Sampene; Brock Polnaszek; Joseph Connor; Erin E Medlin; Lisa Barroilhet Journal: BMC Cancer Date: 2018-10-26 Impact factor: 4.430